- Home
- Applications
- blood penetration tester
Refine by
Blood Penetration Tester Product Applications
22 applications found
Whole blood testing in low volume clinics without incurring high capital costs for large ...
ByProxim Diagnostics Corp. based in Santa Clara, CALIFORNIA (USA)
It is estimated that there are nearly 137 Million Emergency Room Visits per year in the United States ...
ByAtiva Medical based in Shoreview, MINNESOTA (USA)
In today’s world, access to essential services, even ones as simple and critical as a blood test, can be a ...
ByAtiva Medical based in Shoreview, MINNESOTA (USA)
Iron deficiency affects up to one third of the world’s population and is one of the leading risk factors for disability and death worldwide 1. Yet, it is still underdiagnosed and undertreated 2. Iron is essential for the body’s proper functioning and is needed to maintain energy levels and concentration, thus, an iron deficiency can leave patients feeling fatigued, unable to concentrate and cold. It is therefore essential to assess the body’s iron reserves. Ferritin has been scientifically and ...
ByAbionic SA based in Epalinges, SWITZERLAND
The future of Continuous Glucose Monitoring (CGM) is here ...
BySenseonics based in Germantown, MARYLAND (USA)
We are collaborating with leading hospitals, integrated health systems, medical centers and biobanks around the world to conduct studies in order to further develop and validate UDX's blood test for early cancer ...
ByUniversal Diagnostics SL based in Seville, SPAIN
Colorectal cancer (CRC) is the third most common cancer all over the world. About 1.8 million new CRC cases were diagnosed globally in 2018, mostly in developed countries. The incidence of colorectal cancer is increasing in line with the ageing population. Early detection is key to successful treatment of the disease and related cost management. An efficient screening strategy is essential to detect the disease early, when it often does not produce symptoms. The currently available faecal occult blood test (FOBT) ...
ByDiagNodus Ltd. based in Cambridge, UNITED KINGDOM
A NEW WAY TO POWER YOUR DECENTRALIZED CLINICAL TRIALS; Unlock the power of anytime, anywhere blood testing for your program. Tasso Solutions streamline the deployment and execution of at-home testing for ...
ByTasso, Inc. based in Seattle, WASHINGTON (USA)
In the Primary Care segment, blood and urine tests drive nearly 70% of Physician decisions, guiding nearly two-thirds of healthcare ...
ByAtiva Medical based in Shoreview, MINNESOTA (USA)
You need a complete answer to provide the best ...
ByBiocept based in San Diego, CALIFORNIA (USA)
Medica has redefined blood gas analysis, allowing blood tests for critically ill and emergency patients to be performed rapidly and accurately. Medica’s EasyBloodGas™ and EasyStat® analyzers are designed in modular formats with small footprints to save laboratory space. Routine maintenance is limited to the replacement of reagent modules, electrodes, and a single pump tube, minimizing analyzer downtime. Additionally, Medica’s blood gas analyzers digitally store quality-control and patient ...
ByMedica Corporation based in Bedford, MASSACHUSETTS (USA)
The diagnosis of heart failure typically starts when a patient talks to their caregiver about the signs and symptoms they are experiencing. Their health care provider may ask questions designed to confirm the causes of heart failure that may be in their medical history as ...
ByImpulse Dynamics based in Marlton, NEW JERSEY (USA)
Nearly 35% of respiratory allergy sufferers experience both allergic rhinitis and asthma, which impact their quality of life 1,2. Standard diagnostic methods such as skin tests are at times impossible or difficult to perform, have limited reliability and must be performed by trained Allergy and Asthma Specialists. Similarly, laboratory blood tests for specific immunoglobulin E (sIgE) levels have a long turnaround time until results, thus delaying treatment up to several days and requiring multiple visits. Fast and ...
ByAbionic SA based in Epalinges, SWITZERLAND
Custom Power develops battery packs and energy solutions for an extensive range of healthcare applications, including surgical procedures, emergency room use and therapeutic practices. Our in-house capabilities cover all elements of manufacturing, from design and engineering to fabrication and testing. Our engineers and technicians use advanced processes and assembly methods to ensure each product meets or exceeds industry regulations. The team at Custom Power has decades of experience helping customers determine ...
ByCustom Power based in Fountain Valley, CALIFORNIA (USA)
The Ankle Brachial Index is a standard and common method of physiologic assessment of vascular pathology in the lower limbs in a fast and simple ...
ByViasonix based in Ra’anana, ISRAEL
Lower extremity Segmental Blood Pressures (SBP) diagnosis refers to the measurement of the systolic blood pressure at various sites along each ...
ByViasonix based in Ra’anana, ISRAEL
Type 1 diabetes is a common chronic disease, affecting millions of people throughout the world, in which the immune system attacks the body’s own pancreatic cells, stopping the production of insulin. Though it was previously considered a childhood disease, type 1 diabetes is known to affect people at every age, and it has no ...
ByEli Lilly and Company based in Indianapolis, INDIANA (USA)
ATIVA’s rapid low-cost COVID-19 test may provide earlier detection and a safer community. The greatest challenge we face is the spread of infection before symptoms appear. We all want to protect our loved ones, so how do we know if we are carrying the virus? Physical symptoms (fever, cough) appear too late to stop the spread. The nasal swab PCR tests suffer from sampling errors, slow time to results, and are expensive. Early detection of infected people is the key to protecting our most vulnerable people in ...
ByAtiva Medical based in Shoreview, MINNESOTA (USA)
Standard treatment for advanced colorectal cancer generally involves surgical resection and chemotherapy. However, the recent emergence of targeted therapies, particularly those that inhibit EGFR, has provided treatment options that extend survival for a subset of patients. Unfortunately, this benefit does not extend to patients whose tumors contain mutations in EGFR signaling components KRAS and BRAF, which together represent 50% of all colorectal cancers. This makes characterizing these molecular markers an ...
ByBiocept based in San Diego, CALIFORNIA (USA)
A liquid biopsy from Biocept gives you a new tool for profiling breast cancer—with a simple blood ...
ByBiocept based in San Diego, CALIFORNIA (USA)